Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers

British Journal of Clinical Pharmacology

Volumn 65, Issue 1, 2008, Pages 30-39

  Cronenberger, Carol ^a   Mould, Diane R ^a   Roethig, Hans Juergen ^b   Sarkar, Mohamadi ^b,c  

^a Projections Research Inc   (United States)

^b Philip Morris USA Research Center   (United States)

^c Philip Morris USA   (United States)

Author keywords

Carboxyhaemoglobin; FTC; Population pharmacokinetics

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; TAR;

ADULT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHEMICAL ANALYSIS; CIGARETTE SMOKING; COMPARTMENT MODEL; CONTROLLED STUDY; ELIMINATION REACTION; FEMALE; GROUPS BY AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING CESSATION; TOXICOKINETICS;

ADULT; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MODELS, THEORETICAL; SMOKING; TARS;

EID: 37249070328     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02974.x     Document Type: Article

References (47)

1. Green CR, Rodgman A. The Tobacco Chemists' Research Conference: a half century forum for advances in analytical methodology of tobacco and its products. Recent Adv Tobacco Sci 1996 22 : 131 304.
2. Report by the Surgeon General. The Health Consequences of Smoking. Executive Summary: A Report of the Surgen General. Washington, DC : U.S. Public Health Services 2004.
3. Haab P. The effect of carbon monoxide on respiration. Experientia 1990 46 : 1202 6.
4. Salhany JM. Effect of carbon dioxide on human hemoglobin. Kinetic basis for the reduced oxygen affinity. J Biol Chem 1972 247 : 3799 801.
5. Roughton FJ, Darling RC. The effect of carbon monoxide on the oxyhemoglobin dissociation curve. Am J Physiol 1944 141 : 17 31.
6. Caughey WS. Carbon monoxide bonding in hemeproteins. Ann NY Acad Sci 1970 174 : 148 53.
7. Peterson JE, Stewart RD. Predicting the carboxyhemoglobin levels resulting from carbon monoxide exposures. J Appl Physiol 1975 39 : 633 8.
8. Andersen ME, Clewell HJ III., Gargas ML, MacNaughton MG, Reitz RH, Nolan RJ, McKenna MJ. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol Appl Pharmacol 1991 108 : 14 27.
9. Bruce EN, Bruce MC. A multicompartment model of carboxyhemoglobin and carboxymyoglobin responses to inhalation of carbon monoxide. J Appl Physiol 2003 95 : 1235 47.
10. Jones RM, Fagan R. Carboxyhemoglobin in nonsmokers: a mathematical model. Arch Environ Health 1975 30 : 184 9.
11. Coburn RF, Forster RE, Kane PB. Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man. J Clin Invest 1965 44 : 1899 910.
12. Peterson JE, Stewart RD. Absorption and elimination of carbon monoxide by inactive young men. Arch Environ Health 1970 21 : 165 71.
13. Roethig HJ, Kinser RD, Lau RW, Walk RA, Wang N. Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. J Clin Pharmacol 2005 45 : 133 45.
14. Pillsbury HC, Bright CC. Comparison of aliquot and complete sample procedure for the determination of nicotine in cigarette smoke. J Assoc Off Anal Chem 1972 55 : 636 8.
15. Law MR, Morris JK, Watt HC, Wald NJ. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer 1997 75 : 1690 3.
16. Devine D. Case study number 25 gentamicin therapy. Drug Intell Clin 1974 8 : 650 5.
17. Sheiner BL, Beal SL. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J Pharmacokinet Biopharm 1981 9 : 635 51.
18. Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clin Pharmacol Ther 1979 26 : 294 305.
19. Wahlby U, Jonsson EN, Karlsson MO. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 2001 28 : 231 52.
20. Gobburu JV, Lawrence J. Application of resampling techniques to estimate exact significance levels for covariate selection during nonlinear mixed effects model building: some inferences. Pharm Res 2002 19 : 92 8.
21. Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic-pharmacodynamic models. I. Models for covariate effects. J Pharmacokinet Biopharm 1992 20 : 511 28.
22. Yafune A, Ishiguro M. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I. A use of bootstrap standard error. Stat Med 1999 18 : 581 99.
23. Yano Y, Beal SL, Sheiner LB. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check. J Pharmacokinet Pharmacodyn 2001 28 : 171 92.
24. Ette EI, Onyiah LC. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization. Eur J Drug Metab Pharmacokinet 2002 27 : 213 24.
25. Shete S, Beasley TM, Etzel CJ, Fernandez JR, Chen J, Allison DB, Amos CI. Effect of winsorization on power and type 1 error of variance components and related methods of QTL detection. Behav Genet 2004 34 : 153 9.
26. Roughton FJ. Kinetics of gas transport in the blood. Br Med Bull 1963 19 : 80 9.
27. Coburn RF, Williams WJ, White P, Kahn SB. The production of carbon monoxide from hemoglobin in vivo. J Clin Invest 1967 46 : 346 56.
28. Blomberg LM, Blomberg MR, Siegbahn PE. A theoretical study on the binding of O(2), NO and CO to heme proteins. J Inorg Biochem 2005 99 : 949 58.
29. Lim M, Jackson TA, Anfinrud PA. Binding of CO to myoglobin from a heme pocket docking site to form nearly linear Fe-C-O. Science 1995 269 : 962 6.
30. Omura T, Sato R, Cooper DY, Rosenthal O, Estabrook RW. Function of cytochrome P-450 of microsomes. Fed Proc 1965 24 : 1181 9.
31. Hill BC. The pathway of CO binding to cytochrome c oxidase. Can the gateway be closed? FEBS Lett 1994 354 : 284 8.
32. Yoshikawa S, Choc MG, O'Toole MC, Caughey WS. An infrared study of CO binding to heart cytochrome c oxidase and hemoglobin A. Implications re O2 reactions. J Biol Chem 1977 252 : 5498 508.
33. Shimazu T, Ikeuchi H, Sugimoto H, Goodwin CW, Mason AD Jr., Pruitt BA Jr. Half-life of blood carboxyhemoglobin after short-term and long-term exposure to carbon monoxide. J Trauma 2000 49 : 126 31.
34. Muranaka H, Higashi E, Itani S, Shimizu Y. Evaluation of nicotine, cotinine, thiocyanate, carboxyhemoglobin, and expired carbon monoxide as biochemical tobacco smoke uptake parameters. Int Arch Occup Environ Health 1988 60 : 37 41.
35. Turner JA, McNicol MW, Sillett RW. Distribution of carboxyhaemoglobin concentrations in smokers and non-smokers. Thorax 1986 41 : 25 7.
36. Wagner JA, Horvath SM, Dahms TE. Carbon monoxide elimination. Respir Physiol 1975 23 : 41 7.
37. Weaver LK, Howe S, Hopkins R, Chan KJ. Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest 2000 117 : 801 8.
38. Piantadosi CA. Carbon monoxide poisoning. Undersea Hyperb Med 2004 31 : 167 77.
39. Myers RA, Snyder SK, Emhoff TA. Subacute sequelae of carbon monoxide poisoning. Ann Emerg Med 1985 14 : 1163 7.
40. Burney RE, Wu SC, Nemiroff MJ. Mass carbon monoxide poisoning: clinical effects and results of treatment in 184 victims. Ann Emerg Med 1982 11 : 394 9.
41. Pace N, Strajman E, Walker EL. Acceleration of carbon monoxide elimination in man by high pressure oxygen. Science 1950 111 : 652 4.
42. McArdle WD, Katch FI, Katch VL. Exercise Physiology: Energy Nutrition, and Human Performance. 2nd edn. Chapter 14 part 2. Philadelphia, PA : Lea & Febiger 1986.
43. Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA 1990 264 : 1556 9.
44. Guyton AC. Basic Human Physiology: Normal Function and Mechanisms of Disease, 2nd edn. Chapter 28. Philadelphia, PA : W.B. Saunders, Co. 1977.
45. Mathews CK, van Holde KE. Biochemistry, Chapter 7. Redwood City, CA : Benjamin / Cummings Publications Co. Inc. 1990 :
46. Griffen KI. Medical Information: Carbon Monoxide Poisoning; New Thinking about an Old Toxin. Tracker 2004 7 : 10 12.
47. McNeill AD, West R, Jarvis MJ, Russell MA. Do older children take in more smoke from their cigarettes? Evidence from carbon monoxide levels. J Behav Med 1986 9 : 559 65.